Profusa, Inc. Common Stock
Profusa, Inc. develops bioengineered sensors for body to detect and continuously transmit clinical-grade data for personal and medical use in the United States. It offers the Lumee Oxygen Platform to monitor compromised tissue for peripheral artery disease, chronic wounds, and reconstructive surgery. The company researches and develops the Lumee Glucose Platform which is designed to monitor gluco… Read more
Profusa, Inc. Common Stock (PFSA) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.313x
Based on the latest financial reports, Profusa, Inc. Common Stock (PFSA) has a cash flow conversion efficiency ratio of 0.313x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-10.62 Million) by net assets ($-33.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Profusa, Inc. Common Stock - Cash Flow Conversion Efficiency Trend (2021–2024)
This chart illustrates how Profusa, Inc. Common Stock's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Profusa, Inc. Common Stock Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Profusa, Inc. Common Stock ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
PARKER-HANNIFIN CO. - Dusseldorf Stock Exchang
DU:PAR
|
0.058x |
|
Bolt Biotherapeutics
NASDAQ:BOLT
|
-0.303x |
|
Freightos Limited Warrants
NASDAQ:CRGOW
|
-0.069x |
|
Tong Hua Holding Public Company Limited
BK:TH
|
0.002x |
|
Equites Property Fund Ltd
JSE:EQU
|
0.035x |
|
Nureca Limited
NSE:NURECA
|
0.022x |
|
Lipum AB
ST:LIPUM
|
1.465x |
|
PIONEER MEDIA HOLDINGS
F:6NU
|
N/A |
Annual Cash Flow Conversion Efficiency for Profusa, Inc. Common Stock (2021–2024)
The table below shows the annual cash flow conversion efficiency of Profusa, Inc. Common Stock from 2021 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $-119.20 Million | $-2.07 Million | 0.017x | -56.69% |
| 2023-12-31 | $-110.00 Million | $-4.40 Million | 0.040x | -48.16% |
| 2022-12-31 | $-99.77 Million | $-7.70 Million | 0.077x | -39.59% |
| 2021-12-31 | $-83.66 Million | $-10.69 Million | 0.128x | -- |